Biowatch

United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy

United Therapeutics Acquires Thymmune, Betting 460 Billion Won on Thymus Cell Therapy

The race to develop regenerative cell therapies for an ultra-rare disease that leaves patients born without a thymus—making them highly vulnerable to...
Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone

Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone

South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1 class anti-obesity...
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients

ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients

South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio

Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...
GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea

GC Biopharma to Conduct Phase 3 Clinical Trial for Two-Dose Chickenpox Vaccine in South Korea

GC Biopharma’s chickenpox vaccine, Barycela Inj., is set to enter a Phase 3 clinical trial in South Korea to confirm...
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
Celltrion Secures Historic FDA Interchangeability Status for Truxima

Celltrion Secures Historic FDA Interchangeability Status for Truxima

Celltrion announced on the 1st that the U.S. Food and Drug Administration has granted interchangeable status to Truxima...
Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals

Fueling the Future of Biohealth: InterBiz Forum Opens in Jeju With a Record 1,500 Tech Deals

The 24th InterBiz Bio Partnering & Investment Forum 2026, a premier biohealth technology deal-making event, opened...
Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco

Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco

Waking up frequently at night to urinate or noticing a weaker urine stream is a common health concern for men as they...